<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" dtd-version="2.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JFR</journal-id>
      <journal-id journal-id-type="nlm-ta">JMIR Form Res</journal-id>
      <journal-title>JMIR Formative Research</journal-title>
      <issn pub-type="epub">2561-326X</issn>
      <publisher>
        <publisher-name>JMIR Publications</publisher-name>
        <publisher-loc>Toronto, Canada</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">v9i1e50536</article-id>
      <article-id pub-id-type="pmid">40146987</article-id>
      <article-id pub-id-type="doi">10.2196/50536</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Letter</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Research Letter</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Exploring Public Sentiment on the Repurposing of Ivermectin for COVID-19 Treatment: Cross-Sectional Study Using Twitter Data</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Mavragani</surname>
            <given-names>Amaryllis</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Gore</surname>
            <given-names>Ross</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Plasek</surname>
            <given-names>Joseph</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Naser</surname>
            <given-names>Abdallah</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Cao</surname>
            <given-names>Ba</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib id="contrib1" contrib-type="author" corresp="yes" equal-contrib="yes">
          <name name-style="western">
            <surname>Kautsar</surname>
            <given-names>Angga Prawira</given-names>
          </name>
          <degrees>MBA</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <address>
            <institution>Unit of Global Health, Department of Health Sciences</institution>
            <institution>University Medical Center Groningen</institution>
            <institution>University of Groningen</institution>
            <addr-line>Antonius Deusinglaan 1</addr-line>
            <addr-line>Groningen, 9713 AV</addr-line>
            <country>The Netherlands</country>
            <phone>31 0503611111</phone>
            <email>angga.prawira@unpad.ac.id</email>
          </address>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff3" ref-type="aff">3</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-6868-5286</ext-link>
        </contrib>
        <contrib id="contrib2" contrib-type="author" equal-contrib="yes">
          <name name-style="western">
            <surname>Sinuraya</surname>
            <given-names>Rano Kurnia</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff4" ref-type="aff">4</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-6109-0482</ext-link>
        </contrib>
        <contrib id="contrib3" contrib-type="author">
          <name name-style="western">
            <surname>van der Schans</surname>
            <given-names>Jurjen</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff5" ref-type="aff">5</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-6170-1191</ext-link>
        </contrib>
        <contrib id="contrib4" contrib-type="author">
          <name name-style="western">
            <surname>Postma</surname>
            <given-names>Maarten Jacobus</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff5" ref-type="aff">5</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-6306-3653</ext-link>
        </contrib>
        <contrib id="contrib5" contrib-type="author">
          <name name-style="western">
            <surname>Suwantika</surname>
            <given-names>Auliya A</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff4" ref-type="aff">4</xref>
          <xref rid="aff6" ref-type="aff">6</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-8671-2065</ext-link>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution>Unit of Global Health, Department of Health Sciences</institution>
        <institution>University Medical Center Groningen</institution>
        <institution>University of Groningen</institution>
        <addr-line>Groningen</addr-line>
        <country>The Netherlands</country>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution>Department of Pharmaceutics and Pharmaceutical Technology</institution>
        <institution>Faculty of Pharmacy</institution>
        <institution>Universitas Padjadjaran</institution>
        <addr-line>Sumedang</addr-line>
        <country>Indonesia</country>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution>Center of Excellence in Higher Education for Pharmaceutical Care Innovation</institution>
        <institution>Universitas Padjadjaran</institution>
        <addr-line>Bandung</addr-line>
        <country>Indonesia</country>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <institution>Department of Pharmacology and Clinical Pharmacy</institution>
        <institution>Faculty of Pharmacy</institution>
        <institution>Universitas Padjadjaran</institution>
        <addr-line>Sumedang</addr-line>
        <country>Indonesia</country>
      </aff>
      <aff id="aff5">
        <label>5</label>
        <institution>Department of Economics, Econometrics and Finance</institution>
        <institution>Faculty of Economics and Business</institution>
        <institution>University of Groningen</institution>
        <addr-line>Groningen</addr-line>
        <country>Indonesia</country>
      </aff>
      <aff id="aff6">
        <label>6</label>
        <institution>Center for Health Technology Assessment</institution>
        <institution>Universitas Padjadjaran</institution>
        <institution>Universitas Padjadjaran</institution>
        <addr-line>Bandung</addr-line>
        <country>Indonesia</country>
      </aff>
      <author-notes>
        <corresp>Corresponding Author: Angga Prawira Kautsar <email>angga.prawira@unpad.ac.id</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2025</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>3</month>
        <year>2025</year>
      </pub-date>
      <volume>9</volume>
      <elocation-id>e50536</elocation-id>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>7</month>
          <year>2023</year>
        </date>
        <date date-type="rev-request">
          <day>16</day>
          <month>11</month>
          <year>2023</year>
        </date>
        <date date-type="rev-recd">
          <day>12</day>
          <month>2</month>
          <year>2024</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>9</month>
          <year>2024</year>
        </date>
      </history>
      <copyright-statement>©Angga Prawira Kautsar, Rano Kurnia Sinuraya, Jurjen van der Schans, Maarten Jacobus Postma, Auliya A Suwantika. Originally published in JMIR Formative Research (https://formative.jmir.org), 27.03.2025.</copyright-statement>
      <copyright-year>2025</copyright-year>
      <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.</p>
      </license>
      <self-uri xlink:href="https://formative.jmir.org/2025/1/e50536" xlink:type="simple"/>
      <abstract>
        <p>A sentiment analysis of 5051 Twitter posts from January 2022 found that 53.4% of them expressed positive views on ivermectin as a COVID-19 treatment, 35.6% of them were neutral, and 11% of them were negative, highlighting the polarized public perception and the need for careful interpretation of social media data in health communication.</p>
      </abstract>
      <kwd-group>
        <kwd>COVID-19</kwd>
        <kwd>ivermectin</kwd>
        <kwd>sentiment analysis</kwd>
        <kwd>Twitter</kwd>
        <kwd>social media</kwd>
        <kwd>public health</kwd>
        <kwd>misinformation</kwd>
        <kwd>geolocation analysis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction">
      <title>Introduction</title>
      <p>As the COVID-19 pandemic evolves, the scientific community confronts the limitations of vaccines due to emerging viral mutations that potentially decrease vaccine efficacy [<xref ref-type="bibr" rid="ref1">1</xref>], thus necessitating a parallel investigation into additional therapeutic agents. Ivermectin, a well-established, safe drug, has emerged as a repurposed drug candidate due to preliminary studies suggesting its antiviral properties against SARS-CoV-2 in vitro [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>]. Nonetheless, the scientific debate remains vigorous, with discussions on the drug’s appropriate formulation and dosing for potential COVID-19 prophylaxis and treatment [<xref ref-type="bibr" rid="ref3">3</xref>].</p>
      <p>Simultaneously, ivermectin’s role has garnered widespread attention on social media, reflecting the public's quest for alternative treatments. Twitter (now X), a hub for real-time public discourse, has become a fertile ground for divergent views on COVID-19 treatment [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>]. This sentiment analysis focuses on Twitter discussions about ivermectin, showing public opinion that, while not devoid of misinformation risks, these discussions offer an alternative lens to understand the societal pulse on this contentious topic [<xref ref-type="bibr" rid="ref6">6</xref>]. By examining the sentiments expressed on Twitter, we aim to add nuance to the ongoing discourse, acknowledging the platform's influence on public perception and its implications for health communication strategies.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Overview</title>
        <p>This cross-sectional examined the COVID-19–related sentiments on ivermectin using Twitter data. Primary data were collected from Twitter posts about ivermectin worldwide from January 15 to 22, 2022. We searched posts with the keyword “ivermectin” and retrieved raw data with various variables. Data cleaning involved lowercasing capital letters, eliminating retweet symbols, removing punctuation marks, and other preprocessing steps to ensure data accuracy [<xref ref-type="bibr" rid="ref6">6</xref>]. People’s sentiments were determined by creating a corpus (body of text) and loading a lexicon dictionary based on the positive and negative words. The sentiment score was calculated with the Bing method using a range of –6 to +6 and considered 3 sentiment types: positive, neutral, and negative [<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref>]. The Bing lexicon was chosen for its proven effectiveness and simplicity in extensive dataset analysis. Frequency analysis of single terms (unigrams), word pairs (bigrams), and bigram networks helped identify frequently mentioned terms and explore relationships between words [<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref>]. Despite its simplicity, this approach is as robust as more complex methods, as it accurately categorizes sentiments and identifies patterns through unigram and bigram frequency analysis [<xref ref-type="bibr" rid="ref6">6</xref>]. This computational analysis–focused methodology offers valuable insights into public sentiment, complementing traditional clinical evaluation without extensive statistical validation. Data were mined using Twitter’s limited application programming interface (version 2) and analyzed using RStudio (R Foundation) and relevant packages for visualization.</p>
      </sec>
      <sec>
        <title>Ethical Considerations</title>
        <p>There was no direct connection with Twitter users. We removed all individual data, usernames, IDs, and tweets in the manuscript and supporting material. Therefore, ethical approval was not required.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>In total, 5051 ivermectin-related tweets underwent sentiment analysis, revealing a prevailing positive sentiment (53.4%), followed by neutral (35.6%) and negative (11%) sentiments among the analyzed tweets (<xref rid="figure1" ref-type="fig">Figure 1</xref>). The analysis identified frequently mentioned positive terms such as “medication,” “potentially,” and “treatment,” while negative terms like “poised,” “smuggling,” and “toxic” were less common. Notably, analysis of word pairings unveiled strong associations with positive sentiments, further supporting the notion of ivermectin’s potential efficacy in COVID-19 treatment. Examining these word pairings facilitated in-depth exploration of sentiment patterns within the bigram network, revealing significant connections and relationships in the analyzed tweets (<xref rid="figure2" ref-type="fig">Figure 2</xref>).</p>
      <fig id="figure1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Distribution of sentiment score.</p>
        </caption>
        <graphic xlink:href="formative_v9i1e50536_fig1.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
      </fig>
      <fig id="figure2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Bigram count network related to tweets ivermectin.</p>
        </caption>
        <graphic xlink:href="formative_v9i1e50536_fig2.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <sec>
        <title>Principal Findings</title>
        <p>Our analysis shows that tweets about repurposing ivermectin for COVID-19 treatment are predominantly positive. Terms like “medication,” “potentially,” and “treatment” frequently appeared in positive contexts, reinforcing this finding. Phrases such as “ivermectin works,” “available ivermectin,” and “ivermectin medication” were strongly associated with positive sentiment. These results align with previous findings showing ivermectin’s popularity on Twitter for COVID-19 treatment [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>]. However, some negative sentiment was observed, particularly concerning warnings from the Food and Drug Administration and the limited clinical evidence supporting ivermectin’s efficacy in COVID-19 prevention and treatment [<xref ref-type="bibr" rid="ref9">9</xref>].</p>
        <p>Twitter data have proven valuable in monitoring public responses to the COVID-19 pandemic, as evidenced by a study of millions of SARS-CoV-2–related tweets [<xref ref-type="bibr" rid="ref10">10</xref>]. This study not only identified dominant topics like new cases, death rates, and preventive measures, but also explored the geographic distribution of sentiments through tweet-embedded geolocation data (code available in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>).</p>
      </sec>
      <sec>
        <title>Limitations</title>
        <p>Of note, the findings are based on Twitter data, which may not represent the entire population’s sentiments. Therefore, researchers conducted cross-validation of the sources.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p>This sentiment analysis highlights the polarized perception of ivermectin in COVID-19–related discourse and reflects broader public health debates. Given the regulatory advisories and the limited clinical evidence, these public sentiments must be interpreted cautiously.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <supplementary-material id="app1">
        <label>Multimedia Appendix 1</label>
        <p>Code in R.</p>
        <media xlink:href="formative_v9i1e50536_app1.zip" xlink:title="ZIP File  (Zip Archive), 5 KB"/>
      </supplementary-material>
    </app-group>
    <ack>
      <p>We acknowledge receiving the Ministry of Higher Education, Science, and Technology Overseas Postgraduate Education scholarship (DIKTI BPP-LN grant T/915/D3.2/KD.02.01/2019) awarded to AK. Despite this financial support, we have diligently maintained transparency and objectivity in our work.</p>
    </ack>
    <fn-group>
      <fn fn-type="conflict">
        <p>None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees</article-title>
          <source>Nature</source>
          <year>2020</year>
          <month>03</month>
          <day>16</day>
          <volume>579</volume>
          <issue>7799</issue>
          <fpage>321</fpage>
          <lpage>321</lpage>
          <pub-id pub-id-type="doi">10.1038/d41586-020-00751-9</pub-id>
          <pub-id pub-id-type="medline">32179860</pub-id>
          <pub-id pub-id-type="pii">10.1038/d41586-020-00751-9</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Caly</surname>
              <given-names>Leon</given-names>
            </name>
            <name name-style="western">
              <surname>Druce</surname>
              <given-names>Julian D</given-names>
            </name>
            <name name-style="western">
              <surname>Catton</surname>
              <given-names>Mike G</given-names>
            </name>
            <name name-style="western">
              <surname>Jans</surname>
              <given-names>David A</given-names>
            </name>
            <name name-style="western">
              <surname>Wagstaff</surname>
              <given-names>Kylie M</given-names>
            </name>
          </person-group>
          <article-title>The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro</article-title>
          <source>Antiviral Res</source>
          <year>2020</year>
          <month>06</month>
          <volume>178</volume>
          <fpage>104787</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S0166-3542(20)30201-1"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.antiviral.2020.104787</pub-id>
          <pub-id pub-id-type="medline">32251768</pub-id>
          <pub-id pub-id-type="pii">S0166-3542(20)30201-1</pub-id>
          <pub-id pub-id-type="pmcid">PMC7129059</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>The</surname>
              <given-names>WP</given-names>
            </name>
          </person-group>
          <article-title>NIH trial may settle debate over ivermectin as a covid-19 treatment</article-title>
          <source>The Washington Post</source>
          <access-date>2023-03-06</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.washingtonpost.com/health/2021/04/08/ivermectin-covid-drug/">https://www.washingtonpost.com/health/2021/04/08/ivermectin-covid-drug/</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>de Melo</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Figueiredo</surname>
              <given-names>CMS</given-names>
            </name>
          </person-group>
          <article-title>Comparing news articles and tweets about COVID-19 in Brazil: sentiment analysis and topic modeling approach</article-title>
          <source>JMIR Public Health Surveill</source>
          <year>2021</year>
          <month>02</month>
          <day>10</day>
          <volume>7</volume>
          <issue>2</issue>
          <fpage>e24585</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://publichealth.jmir.org/2021/2/e24585/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/24585</pub-id>
          <pub-id pub-id-type="medline">33480853</pub-id>
          <pub-id pub-id-type="pii">v7i2e24585</pub-id>
          <pub-id pub-id-type="pmcid">PMC7886485</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Garcia</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Berton</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Topic detection and sentiment analysis in Twitter content related to COVID-19 from Brazil and the USA</article-title>
          <source>Appl Soft Comput</source>
          <year>2021</year>
          <month>03</month>
          <volume>101</volume>
          <fpage>107057</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/33519326"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.asoc.2020.107057</pub-id>
          <pub-id pub-id-type="medline">33519326</pub-id>
          <pub-id pub-id-type="pii">S1568-4946(20)30995-9</pub-id>
          <pub-id pub-id-type="pmcid">PMC7832522</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Hill</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Scott</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Developing an Approach to Harvesting, Cleaning, and Analyzing Data from Twitter Using R</article-title>
          <source>Inf Sys Educ J</source>
          <year>2017</year>
          <volume>15</volume>
          <issue>3</issue>
          <fpage>15</fpage>
        </nlm-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <nlm-citation citation-type="confproc">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Hu</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Cheng</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Opinion observer: analyzing and comparing opinions on the Web</article-title>
          <year>2005</year>
          <conf-name>WWW '05: Proceedings of the 14th international conference on World Wide Web</conf-name>
          <conf-date>May 10-14, 2005</conf-date>
          <conf-loc>Chiba, Japan</conf-loc>
          <fpage>342</fpage>
          <lpage>351</lpage>
          <pub-id pub-id-type="doi">10.1145/1060745.1060797</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <nlm-citation citation-type="book">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <source>Sentiment Analysis: Mining Opinions, Sentiments, and Emotions</source>
          <year>2020</year>
          <publisher-loc>Cambridge, United Kingdom</publisher-loc>
          <publisher-name>Cambridge University Press</publisher-name>
        </nlm-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <nlm-citation citation-type="web">
          <article-title>Why You Should Not Use Ivermectin to Treat or Prevent COVID-19</article-title>
          <source>Food and Drug Administration</source>
          <access-date>2022-03-01</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://nycourts.gov/reporter/webdocs/Why-You-Should-Not-Use-Ivermectin-to-Treat-or-Prevent-COVID-19.pdf">https://nycourts.gov/reporter/webdocs/Why-You-Should-Not-Use-Ivermectin-to-Treat-or-Prevent-COVID-19.pdf</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Xue</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Hu</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Chen</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Zheng</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Su</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Zhu</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Twitter discussions and emotions about the COVID-19 pandemic: machine learning approach</article-title>
          <source>J Med Internet Res</source>
          <year>2020</year>
          <month>11</month>
          <day>25</day>
          <volume>22</volume>
          <issue>11</issue>
          <fpage>e20550</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2020/11/e20550/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/20550</pub-id>
          <pub-id pub-id-type="medline">33119535</pub-id>
          <pub-id pub-id-type="pii">v22i11e20550</pub-id>
          <pub-id pub-id-type="pmcid">PMC7690968</pub-id>
        </nlm-citation>
      </ref>
    </ref-list>
  </back>
</article>
